$57.07 0.5%
IRTC Stock Price vs. AI Score
Data gathered: October 13

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About iRhythm Technologies

iRhythm is a digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining our wearable biosensing technology with cloud-based data analytics and machine- learning capabilities.


iRhythm Technologies
Price $57.07
Target Price Sign up
Volume 600,140
Market Cap $1.79B
Year Range $57.07 - $121.38
Dividend Yield 0%
Analyst Rating 91% buy
Industry Medical & Dental Instruments

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q2 '24148M45M103M-20M-11M-0.610
Q1 '24132M44M88M-46M-38M-1.230
Q4 '23133M45M87M-39M-33M-1.260
Q3 '23125M42M82M-27M-22M-0.890
Q2 '23124M38M86M-18M-14M-0.610

Insider Transactions View All

Bobzien Brice filed to sell 24,428 shares at $70.3.
August 12 '24
Smith Mervin filed to sell 10,360 shares at $74.7.
August 5 '24
Patterson Chad filed to sell 37,133 shares at $74.7.
August 5 '24
Turakhia Minang filed to sell 27,255 shares at $105.7.
July 3 '24
Rosenbaum Marc W. filed to sell 8,174 shares at $88.9.
June 5 '24

What is the Market Cap of iRhythm Technologies?

The Market Cap of iRhythm Technologies is $1.79B.

What is the current stock price of iRhythm Technologies?

Currently, the price of one share of iRhythm Technologies stock is $57.07.

How can I analyze the IRTC stock price chart for investment decisions?

The IRTC stock price chart above provides a comprehensive visual representation of iRhythm Technologies' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling iRhythm Technologies shares. Our platform offers an up-to-date IRTC stock price chart, along with technical data analysis and alternative data insights.

Does IRTC offer dividends to its shareholders?

As of our latest update, iRhythm Technologies (IRTC) does not offer dividends to its shareholders. Investors interested in iRhythm Technologies should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of iRhythm Technologies?

Some of the similar stocks of iRhythm Technologies are Align Technology, Dentsply, LeMaitre Vascular, NovoCure, and Silk Road Medical.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.